2-240877534-C-G

Variant summary

Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong

The NM_000030.3(AGXT):​c.847-3C>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000834 in 1,546,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000089 ( 0 hom. )

Consequence

AGXT
NM_000030.3 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.9990
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:10

Conservation

PhyloP100: -0.158
Variant links:
Genes affected
AGXT (HGNC:341): (alanine--glyoxylate aminotransferase) This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 11 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 2-240877534-C-G is Pathogenic according to our data. Variant chr2-240877534-C-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 204169.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-240877534-C-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
AGXTNM_000030.3 linkuse as main transcriptc.847-3C>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000307503.4 NP_000021.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
AGXTENST00000307503.4 linkuse as main transcriptc.847-3C>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_000030.3 ENSP00000302620 P1
AGXTENST00000470255.1 linkuse as main transcriptn.622C>G non_coding_transcript_exon_variant 1/32

Frequencies

GnomAD3 genomes
AF:
0.0000328
AC:
5
AN:
152240
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000463
AC:
7
AN:
151310
Hom.:
0
AF XY:
0.0000500
AC XY:
4
AN XY:
79926
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000822
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000868
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000890
AC:
124
AN:
1393956
Hom.:
0
Cov.:
31
AF XY:
0.0000757
AC XY:
52
AN XY:
686930
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000567
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000112
Gnomad4 OTH exome
AF:
0.0000173
GnomAD4 genome
AF:
0.0000328
AC:
5
AN:
152358
Hom.:
0
Cov.:
34
AF XY:
0.0000403
AC XY:
3
AN XY:
74506
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000284
Hom.:
0
Bravo
AF:
0.0000340

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary hyperoxaluria, type I Pathogenic:7
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsDec 25, 2021- -
Likely pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityMar 10, 2022- -
Pathogenic, criteria provided, single submitterclinical testingLaboratory of Medical Genetics, National & Kapodistrian University of AthensJul 27, 2018PS4, PM2, PP4, PP5 -
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsMar 26, 2024- -
Pathogenic, criteria provided, single submitterclinical testingCounsylAug 18, 2016- -
Pathogenic, no assertion criteria providedresearchClinical Biochemistry Laboratory, Health Services LaboratoryNov 27, 2014- -
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 28, 2023This sequence change falls in intron 8 of the AGXT gene. It does not directly change the encoded amino acid sequence of the AGXT protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs180177286, gnomAD 0.01%). This variant has been observed in individual(s) with primary hyperoxaluria (PMID: 10862087, 20549407, 22844106, 25363903, 25629080). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as c.969-3C>G and IVS8-3C>G. ClinVar contains an entry for this variant (Variation ID: 204169). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Likely pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2022- -
AGXT-related disorder Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 22, 2024The AGXT c.847-3C>G variant is predicted to interfere with splicing. This variant is also referred to as c.969-3C>G or IVS8-3C>G in the literature. It has been reported in the compound heterozygous and homozygous states in many individuals with primary hyperoxaluria (see, for example, Basmaison et al. 2000. PubMed ID: 10862087; Williams et al. 2015. PubMed ID: 25629080; Deesker et al. 2022. PubMed ID: 35812297). This variant is reported in 0.011% of alleles in individuals of European (non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Uncertain
23
DANN
Benign
0.84
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.91
SpliceAI score (max)
0.96
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.96
Position offset: 1
DS_AL_spliceai
0.95
Position offset: 3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs180177286; hg19: chr2-241816951; API